NYSE:USNA USANA Health Sciences Q3 2026 Earnings Date & Estimates $15.18 -0.28 (-1.78%) Closing price 03:59 PM EasternExtended Trading$15.19 +0.00 (+0.03%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. USANA Health Sciences is scheduled to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. The conference call is scheduled for November 4, 2026 at 11:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 3, 2026TimeAfter Market ClosesConference Call DateNovember 4, 2026Conference Call11:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from USANA Health Sciences in Q3 2026USANA Health Sciences is expected to post earnings of $0.43 per share on revenue of $217.42 million. In the same quarter a year earlier USANA Health Sciences reported -$0.15 per share on revenue of $213.67 million. USANA Health Sciences last reported on August 4, 2026, posting -$0.07 per share and missing the $0.43 consensus estimate. USANA Health Sciences has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.43Expected Revenue$217.42 millionPrior-Year EPS-$0.15Prior-Year Revenue$213.67 millionExpected Revenue Growth+1.8%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.07 (Missed by -$0.50)Last Quarter Revenue$223.27 millionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report USANA Health Sciences Q3 2026 Earnings FAQ When does USANA Health Sciences report Q3 2026 earnings? USANA Health Sciences (NYSE:USNA) has confirmed it will report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. What time is USANA Health Sciences' Q3 2026 earnings call? USANA Health Sciences' Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 11:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for USANA Health Sciences? Analysts expect USANA Health Sciences to post earnings of $0.43 per share for Q3 2026. How much revenue is USANA Health Sciences expected to report? The consensus revenue estimate for USANA Health Sciences is $217.42 million for Q3 2026. USANA Health Sciences Earnings HeadlinesUSANA Schedules Third Quarter 2026 Earnings Release and Conference CallOctober 12 at 5:00 PM | businesswire.comUSANA Health Sciences and University Of Utah Athletics Announces New PartnershipOctober 7, 2026 | marketscreener.comMFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.October 14 at 1:00 AM | Weiss Ratings (Ad)USANA Health Sciences Expands Collegiate Athlete Partnerships With UtahOctober 7, 2026 | rttnews.comUSANA Health Sciences (NYSE:USNA) Stock Rating Upgraded by Zacks ResearchOctober 7, 2026 | americanbankingnews.comUSANA Health Sciences and University of Utah Athletics Announce New PartnershipOctober 7, 2026 | prnewswire.comSee More USANA Health Sciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like USANA Health Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on USANA Health Sciences and other key companies, straight to your email. Email Address About USANA Health SciencesUSANA Health Sciences (NYSE:USNA) develops and sells nutritional supplements, personal-care products and foods designed to support general health and wellness. Its product portfolio includes vitamins and mineral supplements, herbal and specialty nutritional products, meal-replacement and snack items, and skincare products marketed under the USANA and Sensé brands. Founded in 1992 by immunologist Myron Wentz, USANA distributes its products primarily through a direct-selling model involving independent associates. The company sells products directly to consumers through its e-commerce platforms and serves markets across North America, Asia-Pacific and other international regions. USANA is headquartered in Salt Lake City, Utah. Its business focuses on research, formulation, manufacturing and distribution of wellness products, with manufacturing operations and quality-control processes supporting its global product portfolio.View USANA Health Sciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Citi Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver?PBF Energy's Stunning Rally Faces a Critical TestA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Albertsons Is Betting on a Turnaround—But Will It Pay Off?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American Business Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
